Physician profile
Jack W Noneman
NPI 1447259502
$828.95
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $271.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $235.79 | 2019-2020 | |
| Abiomed | $121.82 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $103.92 | 2019-2020 | |
| Cardiovascular Systems INC. | $85.62 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.08 | 2019-2020 | |
| Amgen INC. | $43.06 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $33.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.12 | 2019 | |
| Edwards Lifesciences Corporation | $23.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.51 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Noneman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.